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In Brief
Transcription factor binding sites are in promoters. It has therefore been assumed that, in organisms without enhancers, the response of a gene to changes in TF activity is encoded only in the promoter. Using a coupled experimental and mathematical system, Schikora-Tamarit et al. show that this assumption is false.
INTRODUCTION
Understanding how changes in transcription factor activity lead to changes in gene expression is essential for understanding how organisms regulate expression in response to external and internal signals, and for understanding how sequence variation in genomes affects phenotype Levo and Segal, 2014; Ló pez-Maury et al., 2008; Segal and Widom, 2009) . Changes in gene expression are associated with clinically relevant phenotypes such as disease and differential response to drugs, and the current assumption is that much variation in phenotype and expression is due to sequence variation in classical regulatory regions such as enhancers and promoters (Albert and Kruglyak, 2015) . However, current mathematical models of gene expression, while good at predicting the effects of small mutations (Levo and Segal, 2014) , are less good at the ultimate goal, which is predicting expression from sequence (Karr et al., 2012; Yuan et al., 2007) . To quantitatively understand the effects of variation in transcription factor (TF) activity and sequence variation on gene expression, we appear to be missing some key regulatory processes.
Steady-state mRNA levels are determined by the balance between synthesis and degradation rates. These rates are unique to each gene and are determined by the interaction between cis-encoded sequence features (e.g., TF binding sites, transcription terminator, translation initiation site context, codon bias, and binding sites for RNA binding proteins [RBPs] ) and the concentration and activities of trans factors (e.g., TFs, translation initiation factors, RBPs). Further increasing the complexity of predicting mRNA levels from sequence, translation initiation and elongation both affect mRNA stability (Chen et al., 2017; Dvir et al., 2013; Harigaya and Parker, 2016) .
The response of a gene to changes in the concentration and activity of a given trans regulator are generally assumed to be encoded in specific regions of a gene. For example, in organisms that lack enhancers, the response of a gene to changes in TF activity are generally assumed to be encoded in the promoter (Ang et al., 2013; Brophy and Voigt, 2014; Carey et al., 2013; Hansen and O'Shea, 2015; Kim and O'Shea, 2008; van Dijk et al., 2015) . Individual regulatory elements, such as 5 0 UTRs, codon usage, and 3 0 ends (3 0 UTR + transcription terminator) have been interrogated separately (Chen et al., 2017; Dvir et al., 2013; Radhakrishnan et al., 2016; Shalem et al., 2013 Shalem et al., , 2015 Yamanishi et al., 2013) , with the unstated assumption that there is little or no interaction between distinct regulatory elements. However, recent work suggests the existence of a genetic interaction between promoters and codon usage on steady-state mRNA levels (Espinar et al., 2018) , calling into question the idea that these regulatory elements can be fully understood in isolation.
To determine whether sequences external to the promoter can influence the response of a gene to changes in the concentration of TF ([TF]), we generated a library of 42 native yeast genes in which each gene is expressed under the control of the same promoter, with the same 5 0 UTR, and N-terminally tagged with a codon-optimized mCherry. Surprisingly, we find that each gene has a unique response to changes in [TF] and promoter activity. As [TF] increases, some genes increase in expression faster than expected from the promoter alone, which we call promoter activity amplification (PAA), while other genes increase in expression more slowly, which we call promoter activity buffering (PAB). We call the general phenomena promoter activity buffering or amplification (PABA). Sequences outside of the promoter buffer, or amplify, changes in promoter activity. While one possible mechanism for PABA is autoregulation, autoregulation is not responsible for PABA in native genes. Experimental data and mathematical modeling suggest that titration of limiting trans regulators is responsible for PABA in some native genes. Finally, we show that, because PAB reduces the effect of changes in [TF] on gene expression, buffering insulates cells from the potentially deleterious effects of misregulation.
RESULTS

Sensitivity to Changes in [TF] Is Influenced by Sequences External to the Promoter
To directly test whether a gene's sensitivity to changes in [TF] is influenced by elements external to the promoter ( Figure 1A ), we generated a master strain in which [TF] can be varied without affecting any other cellular processes (McIsaac et al., 2013) , and in which promoter activity and protein expression level can be independently measured (Schikora-Tamarit et al., 2016) . The master strain contains the engineered b-estradiol-activated Z 3 EV transcription factor and GFP driven by a Z 3 EV-regulated promoter (Z 3 EVpr). From this master strain, we generated a library of 66 strains. In each strain, a single gene at its native locus had its native promoter replaced with the Z 3 EV promoter driving the expression of a mCherry-gene construct ( Figure 1B) . We used flow cytometry to measure how promoter activity (Z 3 EVpr-GFP) and protein expression level (mCherry) change as function of [TF] (b-estradiol) ( Figure 1C ). Of the 66 tagged genes, 42 gave reproducible results across multiple independent transformants and were used for further study (for a list of genes, see Table S1 ). We found that, in spite of having identical promoters, different genes exhibit vastly different response to changes in both [TF] and promoter activity ( Figures 1C, 1D , and S1).
In comparison to a control strain in which Z 3 EVpr-mCherry is integrated at the his3 locus, we found three types of behavior ( Figure 1D ). For some genes, such as MSL5, expression is offset from the control strain by a constant amount. For other genes, such as RPL11A, at high promoter activity expression increases more slowly than in the control strain. We refer to this as PAB. Finally, for some genes, such as YHC1, at high promoter activity, expression increases more rapidly than in the control strain. We refer to this as PAA.
A Mathematical Model to Quantify PABA To quantify PABA, we built a mathematical model that describes how protein levels change with increasing promoter activity (Experimental Procedures). The model contains three mCherryprotein-specific biological parameters: (1) protein and mRNA synthesis and degradation rates (SD), (2) basal expression (BE) (measured as the fraction of maximum fluorescence in the absence of b-estradiol), and (3) expression (protein) level-dependent regulation of expression (F) (which allows protein levels to feedback on and influence transcription or translation rates) (Experimental Procedures). PABA quantifies protein expression level-dependent regulation of gene expression. Changing each parameter has a unique effect, allowing us to quantitatively isolate the effect of PABA on gene expression, and to predict what expression would look like in the absence of PABA (Figures 2A and 2B) .
Negative autoregulation provides a conceptual and experimental model for PAB. In the presence of negative autoregulation, increased protein levels reduce transcription or translation rates, resulting in less protein than expected in the absence of autoregulation ( Figure 2B ). Conversely, positive autoregulation results in a faster than expected increase in protein levels, and hence results in PAA. To quantify PABA and to test the model, we took advantage of the RPB Puf3, which binds to sequences in the COX17 3 0 UTR, stimulating degradation of the mRNA (Olivas and Parker, 2000) . We generated a strain in which the Z 3 EVpr-mCherry construct contains the COX17 3 0 end (3 0 UTR plus transcription terminator). Compared to a PUF3 + strain, mCherry protein expression in a puf3D strain is increased by a constant offset, consistent with the model (Figures 2A, 2C , and 2D). In contrast, a negative autoregulation strain in which the native PUF3 gene is replaced by Z 3 EVpr-mCherry-PUF3-COX17 3 0 END exhibits PAB, with respect to a Z 3 EVpr-mCherry-PUF3-PUF3 3 0 END strain ( Figures 2E and  2F) . Thus, constant changes in mRNA stability do not buffer protein levels from changes in promoter activity. In contrast, changes in mRNA stability as a function of promoter activity result in PABA in this well-defined synthetic system.
To quantify PABA for each gene, we first fit the model to expression data from the control strain. We next allow either SD and BE to vary or SD, BE, and F to vary. Variation in SD and BE are sufficient to fit the no-feedback strain (R 2 = 0.998), but F is required to fit the negative-feedback strain (SD, BE R 2 = 0.995; SD, BE, F R 2 = 0.999). While this increase in R 2 is small, it is consistent across biological replicates on a model trained on one biological replicate and used to predict a second biological replicate. We then computationally removed feedback (E) As a proof of (B), we used the previously described (Schikora-Tamarit et al., 2016) set of negative-feedback strains. These are built in a Z 3 EVpr-GFP background and express either a Z 3 EVpr-mCherry-Puf3-Cox17 3 0 END or a Z 3 EVpr-mCherry-Puf3-Puf3 3 0 END , resulting in presence and absence of negative feedback. (F) Expression data (dots) of these constructs (together with the control strain in black) is fit (full lines) by a model that implements changes in mCherry basal expression and synthesis/degradation rates in the Puf3-Puf3 3 0 END , but PABA (computed as F [feedback]) is required to fit the Puf3-Cox17 3 0 END strain. However, setting F to 0 in the Puf3-Cox17 3 0 END (dashed orange line) models a curve that fits the Puf3-Puf3 3 0 END data. We thus calculate PABA strength as the mCherry expression ratio of these two models (with [F] and without [F = 0] PABA). It has to be noted that all the Puf3 constructs were engineered using a not yeast codon-optimized mCherry, with the corresponding fluorescence control strain. (G) We measured GFP and mCherry expression in our library (small insets represent two example genes) and quantified PABA strength on them as described above (where dashed lines represent the absence of PABA). Genes can be classified into PAB (orange), amplification (blue), and no PABA (gray).
by setting F to zero, and calculate PABA strength as the change in protein expression at maximal induction when F is set to 0. Consistent with our model, computational removal of PABA by setting F to 0 results in an accurate prediction of expression in the no-feedback strain (Figures 2F).
PABA Is Common and Continuous
To quantify the prevalence of PABA and to predict what expression would look like in the absence of PABA, we fit the model to Z 3 EVpr-mCherry-expression data for 42 native yeast genes. Our model fits experimental data of all genes ( Figure S1 ). We find that PABA is not binary but exists in a continuum, from strong buffering to strong amplification, with PAB being the most prevalent ( Figures 2G and S2F ). The dynamic range of expression observed in our experimental system includes native expression levels ( Figures S2A-S2D ), suggesting that PABA acts in intact native regulatory networks. We note that there is no correlation between PABA and expression level ( Figure S2E ), suggesting that PABA is not due to a general toxicity of overexpression. Buffering can result in more than a 75% reduction (À2-fold change) in expression levels, while amplification can result in a more than a 2-fold increase in expression ( Figure 2G ). These changes in expression are well within the range that natural selection can act on gene expression (Wagner, 2005; Zeevi et al., 2014) . The 42 measured genes cover a diverse class of RBPs involved in splicing, regulation of both transcription and mRNA turnover, and ribosome biogenesis. Twenty-three of our genes have orthologs involved in human disease (Table S1 ). We find that all (five of five) of the genes involved in ribosome biogenesis (NOP12, NOP4, RPL11A, RPL11B, and TIF4631) have PAB (gene ontology [GO] term enrichment, Fisher's exact test, p = 0.019), while all genes involved in mRNA processing (RNA15, SMX3, and YHC1) have PAA (p = 0.037).
Open Reading Frame and 3
0 End Sequences Encode PABA PABA, by definition, is promoter independent. In order to give further mechanistic insights into PABA, we tested whether it is encoded in the open reading frame (ORF) or 3 0 end (3 0 UTRs and transcription terminator) ( Figures 3A and 3B) . To do so, we generated strains in which the native 3 0 end of each gene was replaced with the Ashbya gossypii TEF 3 0 end, resulting in a set of gene::Z 3 EVpr-mCherry-gene ORF -TEF 3 0 END constructs.
The genes chosen included strong PAB (RPL11A, HEK2, NHP2, and RRP40), strong amplification (YHC1), or no PABA (PUF2). We compared the expression of these strains with the corresponding gene::Z 3 EVpr-mCherry-gene ORF -gene 3 0 END strain. Any change in PABA implicates the 3 0 end. Changing the native 3 0 end modifies induction curves in a gene-specific manner (Figures 3C and S2G ). Four of five tested genes (RPL11A, HEK2, NHP2, and RRP40) lose PABA when their 3 0 end is replaced, indicating that both the 3 0 end and the ORF can encode PABA (Figure 3D ). In addition, fusion of 3 0 ends to mCherry confers PABA independently of the location in which the construct is integrated into the genome, although the PABA conferred by the 3 0 end is not always the same as that conferred by the ORF plus 3 0 end, suggesting that, for some genes, PABA is determined by an interaction between these two features ( Figure S7 ). Importantly, changing the 3 0 end affects PABA independent of its effect on protein abundance ( Figures 3C and S2G) . Thus, both the 3 0 ends and ORFs not only play a role in determining absolute protein expression levels but also influence the effect of [TF] and promoter activity on gene expression. 3 0 end regions are well-established regulatory regions, but how often coding sequences play an active role in regulating gene expression is less clear (Plotkin and Kudla, 2011) . To confirm that the ORF sequence itself can be responsible for PABA, we compared the promoter-versus-expression profiles of two mCherry constructs that differ only by synonymous mutations. An mCherry with higher GC content and lower codon bias exhibits PAB ( Figure 3E ), confirming that PABA can be encoded in the ORF.
PABA Is Not Mediated through Autoregulation
Autoregulation is one mechanism by which PABA could be implemented in native genes. In both native and synthetic regulatory networks (Becskei and Serrano, 2000; Eriksson et al., 2012; Springer et al., 2010) , negative autoregulation results in dosage compensation, in which deletion of one copy of a gene results in increased expression of the other copy. Therefore, one way to test for autoregulation is to measure how expression of one allele changes when the other allele in a diploid is deleted. Genes that exhibit PAB should exhibit dosage compensation if PAB is due to negative autoregulation. The same reasoning can be applied to PAA. To test this, we generated diploids in which the other allele of the inducible tagged gene is either wild-type or deleted, and measured protein levels (Figure 4A ). Negative autoregulation results in dosage compensation (increased expression) when the other allele is deleted ( Figure 4B ). The effect is especially strong at low promoter activity, where the native allele contributes more to the total cellular protein concentration. However, no native genes exhibited gene copy number-dependent effects on expression ( Figure 4C ), suggesting that PABA is independent of autoregulation.
Titration of Limiting Regulators Can Explain PABA in Synthetic Constructs
The observation that PABA is mostly encoded in the 3 0 end of genes and that negative autoregulation acting on mRNA stability results in PABA suggested that mRNA stability might be responsible for PABA in native genes. To test this, we searched a dataset of 90 gene-specific features such as codon bias, amino acid properties, and 3 0 UTR length for features that correlate with PABA. We found that mRNA stability-related properties (including codon bias and UTR features) are the only predictors of PABA strength ( Figure S6A ). As the correlation of PABA and mRNA stability is negative ( Figure S6B ), PAB may be a property of stable transcripts, while amplification may be a property of unstable transcripts. Cell-to-cell variability data for some genes are consistent with a change in mRNA stability ( Figure S6C ), although steady-state protein levels are not sufficient to uniquely identify changes in mRNA stability (Baudrimont et al., 2017; Thattai, 2016; Zenklusen et al., 2008) . It is likely that many other biological processes, such as transcription elongation, transcription termination, or protein-complex imbalance-mediated protein degradation can also play a role, and the precise biological factors that determine PABA will be unique to each gene.
The fact that PABA can be encoded in either the ORF or the 3 0 end (Figure 3) suggests that, for each gene, gene-specific mechanisms are involved. We therefore hypothesized one instantiation of a model for PABA. In this model, translation changes as a function of promoter activity due to gene-specific trans regulators being present in limiting amounts. If a positive regulator becomes limiting at high promoter activity, the rate of increase in protein expression will decrease, resulting in PAB. The opposite trend would be observed in a transcript that is unstable due to a limiting trans regulatory factor. We call this the ''trans-element titration'' model for PABA ( Figure 5A ). To test this idea, we used a cox17::Z 3 EVpr-mCherry-COX17 3 0 END strain in which PUF3 is limiting. At high promoter activity, the mCherry mRNA should become increasingly stabilized due to PUF3 titration, resulting in PAA. Experimental data (Figures 5B , 5C, and S6) are consistent with the titration model.
Titration of Limiting Positive Regulators Is a Potential Mechanism for Ploidy-Dependent Dosage Compensation
We found that changing gene copy number in a diploid does not change expression of any of the Z 3 EVpr-mCherry-gene constructs (Figure 4) , which might reveal an interesting behavior in the context of a limiting-regulator titration model. We modeled (Experimental Procedures) the induction profiles of Z 3 EVprmCherry-gene constructs by changing the sign of regulation (positive or negative) and the concentration of regulator ([R]), which results in PABA. Surprisingly, our model predicts that doubling the amount of [R], as would happen in a hemizygous (A) A possible mechanism for PAB is that genes enriched in positive regulators (of transcription, mRNA degradation and/or translation) are efficiently translated at low induction levels. However, when the induction level is high, the loading becomes limiting, and some mRNAs undergo inefficient transcription, degradation, and/or inefficient translation because of titration of the regulator to other transcripts. The opposite would be observed in PAA, as there is an enrichment in negative regulators. (B) A cox17::Z 3 EVpr-mCherry-cox17 3 0 END depicts higher mRNA stability in a Dpuf3 (orange) compared to a (blue) strain (see Figures 2C and  2D) , as Puf3 is a destabilizing regulator of the cox17 3 0 UTR (Schikora-Tamarit et al., 2016).
(C) At high induction, mCherry-COX17 3 0 end exhibits PAA in a PUF3 + strain but not in a puf3D
strain, suggesting that Puf3p may be limiting. The gray lines show the offset curve of the other strain.
diploid with only a single copy of the inducible gene, results in a reduction of PABA toward zero ( Figure 6A ). These findings suggest that PABA (which corresponds, by definition, to dosage-sensitive changes in expression) depends on ploidy in the context of a limiting-factor titration.
To test this prediction, we generated diploid strains expressing the Z 3 EVpr-mCherry-gene constructs. Consistent with the model, PABA is reduced in diploids, and this reduction is stronger for native transcripts, in which PABA is likely due to titration of limiting trans regulator(s), than for the PUF3-COX17 negative autoregulation control strain. ( Figure 6B ). As PAB is the most common phenomena, we conclude that titration of limiting positive regulators is a potential mechanism for ploidy-dependent dosage compensation.
PABA Modifies the Fitness Cost of Promoter Activity
Protein levels of many genes are tightly regulated, and changes in expression level can lead to changes in fitness (Keren et al., 2016; Rest et al., 2013) . Our data suggest that the relationship between promoter activity and expression is gene-specific, and therefore protein expression levels cannot be precisely inferred from measured promoter activity. We therefore sought to determine the mapping between fitness and actual protein levels. A simple model in which expression affects fitness suggests that PABA should modify the fitness effects of changes in [TF] and that PAB also buffers the fitness cost of overexpression ( Figure 7A ).
To test this hypothesis, we measured fitness at different induction levels of the PUF3-COX17 3 0 END synthetic negative autoregulation strain using a flow cytometry-based competition assay (Experimental Procedures). We found that Puf3 lacking negative autoregulation (and lacking PAB) exhibits a large fitness defect at high promoter activity levels. In contrast, the strain with negative autoregulation exhibits PAB and no fitness defect ( Figure 7B ).
To determine the relationship between fitness and protein expression in native genes, we measured fitness for 12 strains (Experimental Procedures). Five genes exhibited a large decrease in fitness at high expression, one exhibited an increase in fitness at high expression, and three exhibited no fitness change ( Figure S3) . Interestingly, the two 60S ribosomal paralogous proteins, RPL11A and RPL11B (homologous to the mammalian L11 and bacterial L5 proteins), both exhibit a nonmonotonic relationship between expression and fitness (Figure S3) , as well as PAB, suggesting that tight regulation of expression of these genes is essential, and that this tight regulation is mediated by PABA.
To determine whether PABA alters the mapping between promoter activity and fitness, we used our mathematical model to predict protein expression in the absence of PABA for native genes. We find that, if a gene has a fitness defect due to overexpression, PAB can increase up to $2-fold the induction level at which the cells exhibit maximal fitness. On the other hand, PAA results in a large growth defect ( Figure 7C) . Therefore, by modifying the mapping between promoter activity and protein expression, PABA changes the fitness landscape of gene expression.
DISCUSSION
By placing diverse native genes at their native genomic locus all under the control of a single inducible promoter and measuring how protein levels changes as a function of promoter activity, we found that the shape of a gene's TF dose-response curve is affected by sequences outside of the promoter. The result is that many genes exhibit PAB, in which the protein abundance increases more slowly than would be expected from the amount of active TF inside the cell. This effect is not due simply to differences in mRNA or protein stability between genes. Instead, it is likely because the molecular mechanisms that regulate gene expression change throughout the induction curve. This effect is often encoded in the 3 0 end of the gene but can be encoded in the ORF as well. While this effect can be implemented by autoregulatory feedback loops, this does not seem to be common in native genes. Instead, it is likely that titration of limiting trans factors plays a major role.
Our data suggest that protein expression levels for more than one-half of genes are influenced not only by TF concentration and activity but also by the copy number of both the gene of interest, and the copy number and expression level of other genes in the cell (Brewster et al., 2014; Buchler and Louis, 2008; van Dijk et al., 2017) . This includes both trans regulators of transcription and translation, other targets of these trans factors, and the copy numbers of physical interaction partners of the protein (Gonç alves et al., 2017; Ishikawa et al., 2017; Kim and Hart, 2017; Ryan et al., 2017; Sung et al., 2016) . One possible mechanism that can explain ORF-encoded PAB, but not obviously PAA, is that proteins that are overexpressed compared with other members of a complex are degraded (McShane et al., 2016) . When this is due to variation in gene copy number, as in the case of a hemizygous diploid, PAB can result in dosage compensation, rescuing haploinsufficiency and providing genetic robustness.
PAB in the mCherry with high GC content and poor codon usage could be explained by the titration of limiting factors models. From the perspective of codon usage, this transcript looks nothing like highly expressed genes in yeast (Harigaya and Parker, 2016; Radhakrishnan et al., 2016) . It is possible that some critical factor, such as a rare tRNA, is titrated away at high expression. Transcriptional elongation may also play a role; the high GC mCherry is predicted to have higher nucleosome occupancy (Kaplan et al., 2009 ). This suggests the existence of a general mechanism to dampen expression, possibly by slowing transcription or translation, and/or accelerating mRNA degradation, when a sub-optimal gene is overexpressed.
The need for PAA, which is less common, is less obvious, as amplification decreases robustness. We note that large Hill coefficients are not uncommon in biology, and that both positivefeedback loops and coherent feedforward loops provide strong non-linear responses to changes in an input signal (Shoval and Alon, 2010) . We note that, while the magnitude of the effects are often small, PABA does measurably reduce the fitness cost of misexpression; Z 3 EVpr-PUF3 strains lacking PAB have a fitness defect when promoter activity is high. Furthermore, it is important to remember that natural selection will act on mutations that affect fitness (selection coefficient) by more than 1/(2*effective population size) ($10 7 in yeast) (Kimura, 1983; Tsai et al., 2008; Wagner, 2005) . This results in very strong evolutionary conservation of gene expression across species. The median difference in expression level between S. cerevisiae and S. mitake ribosomal promoters is less than 10% (Zeevi et al., 2014) . In the lab, we can, at best, measure fitness effects of 0.1%. It is likely that immeasurably small changes are the dominant force shaping evolution in microbes. Protein overexpression and underexpression are often deleterious Kintaka et al., 2016; Mnaimneh et al., 2004; Rest et al., 2013; Sopko et al., 2006) , and yet gene expression and [TF] are noisy Ló -pez-Maury et al., 2008; Nevozhay et al., 2009) . PAB makes cells more robust to short-term fluctuations in [TF] as well as more long-term variation in gene copy number. Regulation of protein expression as a function of promoter activity, but not constant changes in mRNA or protein stability, allows genes to be both highly sensitive to regulated variation in [TF] without incurring a fitness penalty from having too little or too much protein expression.
We identified PABA using a theory-first approach (Phillips, 2015) . In a mathematical model of gene expression in which changes in [TF] regulate expression, and genes differ from each other only by translation efficiency, mRNA or protein stability, all induction curves will have the same shape. Experimentally, we found that this is not true. Thus, identification of PABA shows the strength of theory-inspired experimentation. Likewise, both the hemizygous diploid experiments (Figure 4 ) and haploid versus diploid experiments ( Figure 6 ) were performed to test predictions made by the autoregulation and titration models, respectively. The results in Figure 6B are in line with a rather surprising prediction of the model, and we would not have thought to do the experiment without the model prediction ( Figure 6A ). There are clearly many unknowns, such as the precise molecular mechanism(s) responsible for PABA at each gene. It is the area in which experiment and model disagree that leaves the most to be discovered. GFP (subscript G) is the control protein for growth, cell size, and metabolic and transcriptomic state in our constructs, so we assumed it to follow an induction behavior described by Equation 4, so that: (A) Genes are subjected to PABA (left), and overexpression of many proteins can be deleterious for the cell (middle; Keren et al., 2016) . According to a simple model that relates promoter activity to protein expression and fitness, PABA can enhance or buffer cells from the fitness cost of excessive promoter activity.
(B) As a proof of concept, we measured the fold change in fitness of the two Z 3 EVpr-mCherry-Puf3-Cox17 3 0 END and Z 3 EVpr-mCherry-Puf3-Puf3 3 0 END constructs, at different induction rates. These correspond to the presence and absence to PAB, respectively. Experimental data (dots) are well fit by an impulse function model (lines) as previously described (Chechik et al., 2008 
Fitting Equation 4 to Y212 data (control strain with no feedback, so that both GFP and mCherry are supposed to follow such a behavior), we experimentally found the following relationships:
)
Thus, the model that predicts RFP from GFP (RfG) indicates that:
In order to measure feedback strength (or PABA strength), we fit the RfG equations to Y212 mCherry and GFP fluorescence data, setting F Tl to 0 and then allowed either BE R and Tl R (as an indicator of SD) or BE R , Tl R , and F Tl to vary when fitting RBP strain data. These fits correspond to the ''basal'' and ''feedback'' parameters, respectively. The absence of feedback was modeled setting F to zero from the ''feedback fit.'' We calculate feedback strength (or PABA strength) as the log 2 ratio of mCherry-protein expression between the presence and the absence of feedback, at maximum induction (100 nM b-estradiol). We also computed the difference in R 2 between the two fits as the relevance of the feedback measured. This means that if just allowing BE R and Tl R to vary can explain the data of a construct as well as the case in which F Tl is also changing, we say there is no measurable feedback (F is not necessary to explain our experimental data). Note that the GFP parameters were kept constant as a way to set GFP to be the control protein of the system's activation. Furthermore, we took Tl R as a proxy for SD, as the only parameter that can be uniquely fit is the Tc*Tl/Dp*Dm ratio ( Figure S5 ; Supplemental Experimental Procedures).
BE R was calculated from a fit (so handled as free parameter) to data and not directly from fluorescence values as the latter method could give a biased value for some RBPs (Supplemental Experimental Procedures).
In order classify genes as having or not having feedback (PABA), we need to decide on a threshold for the ability of introducing F as a free parameter to better explain the data (the increase in R 2 upon varying F). To do so, we fit the model to one biological replica of each gene and calculated the R 2 of that fit to data from an independent biological replica, so that the difference in R 2 is a measure of biological and technical noise in the system. We found that the median of these differences was 0.0015, so we assumed that if the fit increases by more than this threshold value when allowing F Tl to vary the feedback measurement is relevant (allowing three parameters to vary always increases the R 2 of a fit compared to allowing two to vary). In addition, we find that 0.0015 is above the R 2 increase in which the associated F diverges between positive
and negative values ( Figure S2F ), indicating that any gene that has a higher R 2 increase has been measured to have a significant feedback strength. This reinforces this thresholding for assigning feedback. We note that these two methods are independent, and yet they agree on similar R 2 increase threshold values.
Mathematical Modeling of the Relationship between Expression and Fitness
Expression-versus-fitness data were modeled using a parametric impulse function (Chechik et al., 2008 ) based on two sigmoid functions fitted to the data. We fit the function as described by Keren et al. (2016) , in which seven free parameters define two sigmoid functions (to allow a proper modeling of both deleterious low and high expression) that predict the relationship between expression and fitness. We fit these to the measured expressionversus-fitness data (which constitutes the ''presence of PABA'' fit) and then inferred fitness from expression in the (predicted) absence of PABA (which corresponds to the ''absence of PABA'' fit). We next compared the GFP (promoter)-versus-fitness relationship in both the ''presence'' and ''absence'' models. 
Mathematical Modeling of the Limiting Regulator Model
DATA AND SOFTWARE AVAILABILITY
The data and codes reported in this study are available at https://github.com/ MikiSchikora/PromoterActivityBuffering2018. 
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